Drug Profile
Research programme: gastrointestinal disorder therapeutics - Nutrition Science Partners
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nutrition Science Partners
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Gastrointestinal-disorders in China
- 29 Nov 2012 Early research in Gastrointestinal disorders in China (unspecified route)